The push to get accountable care organizations to take on risk faster could lead to more participation in Medicare Advantage, said Rob Fields, MD, assistant profession, family medicine and community health, Icahn School of Medicine at Mount Sinai, and senior vice president, chief medical officer, population health at Mount Sinai Health System.
The push to get accountable care organizations to take on risk faster could lead to more participation in Medicare Advantage, said Rob Fields, MD, assistant profession, family medicine and community health, Icahn School of Medicine at Mount Sinai, and senior vice president, chief medical officer, population health at Mount Sinai Health System.
Transcript
With the proposed changes to MSSP, could we see more commercial ACO contracts?
I certainly think we’ll see a growth and a continued movement toward Medicare Advantage, certainly in the world of value. And I say that because for systems that are working in this space, the rules around how Medicare Advantage risk works compared to the Medicare fee-for-service value tracks, the rules are a lot fairer in Medicare Advantage. It’s easier to get the business operations in line with the clinical operations in Medicare Advantage.
So, while that shift already occurs, there are certainly many systems that have taken a Medicare Advantage-only approach, I think that will only get worse. Meaning: a lot more Medicare Advantage and, perhaps, less concentration on regular fee-for-service value contracts. Just because the rules will be too difficult to navigate.
Research has shown that ACOs that have been doing it longer, do better. Is the proposed 2-year timeline to take on risk in MSSP enough time to get it right?
I think the data is really clear that 2 years is probably not enough, that it takes somewhere in the neighborhood of 3 to 4 years to see a system start to perform under these value-based arrangements. Two years, frankly, feels somewhat arbitrary, and not really demonstrating what the data would show.
I do think it’s going to be a problem and leads to the idea that I think it would be difficult for new ACOs that have not been in this space before. You don’t just wake up one day knowing how to take on value and how to take on risk and how to do this kind of work. It takes some time. And we know, actually at this point, how much time it kind of takes for most systems. So, it would be, I think, somewhat more helpful and more effective to design the rule and the path toward risk to be in line with what, actually, the data shows.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More